Cervical lymphadenopathy secondary to rhabdomyosarcoma presenting as Horner syndrome in an infant

Smith, 2010, Incidence of pediatric Horner syndrome and the risk of neuroblastoma: a population-based study, Arch Ophthalmol, 128, 324, 10.1001/archophthalmol.2010.6 Jeffery, 1998, Pediatric Horner syndrome, J AAPOS, 2, 159 Smith, 2010, Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice, Eye (Lond), 24, 1792, 10.1038/eye.2010.125 Mahoney, 2006, Pediatric Horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions, Am J Ophthalmol, 142, 651, 10.1016/j.ajo.2006.05.047 Nolder, 2013, Cervical Lymphadenopathy: when to biopsy?, Current Opinion in Otolaryngology & Head and Neck Surgery, 21, 567 Soldes, 1999, Predictors of malignancy in childhood peripheral lymphadenopathy, J Pediatr Surg, 34, 1447, 10.1016/S0022-3468(99)90101-X National Cancer Institute: PDQ® Childhood Rhabdomyosarcoma Treatment. Bethesda, MD: National Cancer Institute. Available at: http://cancer.gov/cancertopics/pdq/treatment/childrhabdomyosarcoma/HealthProfessional. Accessed 06/16/2014. Pias, 1991, Rhabdomyosarcomas in infancy, 375 Kushner, 2001, Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients, J Clin Oncol, 19, 3397, 10.1200/JCO.2001.19.14.3397